non-HDL cholesterol
Biomarker7 papers4 findings
- Humans3
Interventions
1Orforglipron
downin humans1
1 study
Orforglipron
downin humans1
Orforglipron decreases non-HDL cholesterol in humans (−30.5 mg/dL (P=0.04)).
Humansduring Foundayo usen = 11
Oral Wegovy Is Associated with Greater Early Weight Loss Than Foundayo in Propensity Matched Adult GLP-1 Users · Preprints.org · 28 Sep 2026 · Preprint
Associations
2Atherosclerotic cardiovascular disease
upin humans1
1 study
Atherosclerotic cardiovascular disease
upin humans1
non-HDL cholesterol predicts atherosclerotic cardiovascular disease in humans.
Reviewin large meta-analyses
Non-HDL Cholesterol as a Predictor of Coronary Atherosclerosis in South Asians: A Narrative Review · Current atherosclerosis reports · 30 Sep 2026
non-HDL cholesterol is associated with atherosclerotic cardiovascular disease in humans.
Reviewin South Asians
Non-HDL Cholesterol as a Predictor of Coronary Atherosclerosis in South Asians: A Narrative Review · Current atherosclerosis reports · 30 Sep 2026
Atherosclerotic plaque burden
upin humans1
1 study
Atherosclerotic plaque burden
upin humans1
non-HDL cholesterol is associated with atherosclerotic plaque burden in humans.
Reviewacross imaging modalities
Non-HDL Cholesterol as a Predictor of Coronary Atherosclerosis in South Asians: A Narrative Review · Current atherosclerosis reports · 30 Sep 2026
Latest
8Non-HDL Cholesterol as a Predictor of Coronary Atherosclerosis in South Asians: A Narrative Review
Cumulative non-HDL cholesterol links to cardiovascular risk
Each 100-unit increase in cumulative non-HDL cholesterol carried an adjusted hazard ratio of 1.07 for incident cardiovascular disease over nine years.Each 100-unit increase in cumulative non-HDL cholesterol carried an adjusted hazard ratio of 1.07 for incident cardiovascular disease over nine years.